The response to inhaled nitric oxide in patients with pulmonary artery hypertension is not masked by baseline vasodilator use

Concurrent use of oral vasodilators does not appear to mask a significant response to inhaled NO on the pulmonary vasculature. Therefore, routine discontinuation of pulmonary vasodilators is likely unnecessary before vasodilator testing in patients with pulmonary arterial hypertension.